11/4/24 - $inta - Pass at $50, R/R unclear
11/4/24 :: VROCKSTAR :: 
INTA
Pass at $50, R/R unclear
- nothing i'd fade, growing flexing gross profit vs opex
- also tech B2B have put up good reactions to results all else equal so far this 3Q
- but stonk has gone from low 30s where I punted last Q to ~almost~ doubling. obvioulsy i traded out of this and recycled capital etc. etc. not surprised it kept riding, but so high? a bit surprised.
- don't love fact that stock comp remains high amt of "FCF" though again for stonks that go up, it's less an issue. nonetheless, it's still not real cash earned IMVVHO
- also adjusting for this SBC, PE of near 80x next year and 60x the following remains high.
- i'd rather watch this pitch go by
- a lot of names reporting (and i mean A LOT) this week in perhaps one of the funkiest risk weeks (team blueberry vs. team raspberry gonna have a jam fest). see no reason to punt at these levels, that's all.
- gl to all.
V
INTAPass at $50, R/R unclear
- nothing i'd fade, growing flexing gross profit vs opex
- also tech B2B have put up good reactions to results all else equal so far this 3Q
- but stonk has gone from low 30s where I punted last Q to ~almost~ doubling. obvioulsy i traded out of this and recycled capital etc. etc. not surprised it kept riding, but so high? a bit surprised.
- don't love fact that stock comp remains high amt of "FCF" though again for stonks that go up, it's less an issue. nonetheless, it's still not real cash earned IMVVHO
- also adjusting for this SBC, PE of near 80x next year and 60x the following remains high.
- i'd rather watch this pitch go by
- a lot of names reporting (and i mean A LOT) this week in perhaps one of the funkiest risk weeks (team blueberry vs. team raspberry gonna have a jam fest). see no reason to punt at these levels, that's all.
- gl to all.
V
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.